VivoSim Labs, INC.
VIVS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001497253
In the last 90 days, VivoSim Labs, INC. insiders filed 1 open-market purchase and 0 sales; 25 institutions reported holding it in 13F filings for Q2 2026, worth $109.7K in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding VivoSim Labs, INC. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 26 | 29 | +3 |
| Shares | 128.6K | 220.8K | +92.2K (+71.7%) |
| Value | $189.0K | $644.4K | +$455.4K (+240.9%) |
New holders (11)
Institutions that held VivoSim Labs, INC. at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| DRW Securities, LLC | 67,482 | $197.0K | 0.01% |
| HRT Financial LP | 31,602 | $92.0K | 0.00% |
| Two Sigma Investments, LP | 23,192 | $67.7K | 0.00% |
| Two Sigma Securities, LLC | 18,214 | $53.2K | 0.01% |
| Geode Capital Management, LLC | 17,945 | $52.4K | 0.00% |
| Northern Trust Corp | 10,535 | $30.8K | 0.00% |
| Sound Income Strategies, LLC | 66 | $219 | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 16 | $46 | 0.00% |
| IFP Advisors, Inc | 4 | $12 | 0.00% |
| Signaturefd, LLC | 2 | $6 | 0.00% |
| Rockefeller Capital Management L.P. | 2 | $6 | 0.00% |
Sold out (8)
Institutions that held VivoSim Labs, INC. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Citadel Advisors LLC | 57,493 | $84.5K |
| Susquehanna International Group, LLP | 16,727 | $24.6K |
| Raymond James Financial Inc | 3,313 | $4.87K |
| Total Investment Management Inc | 2 | $3 |
| McIlrath & Eck, LLC | 2 | $3 |
| Koesten, Hirschmann & Crabtree, INC. | 2 | $3 |
| Royal Bank of Canada | 8 | $0 |
| TSFG, LLC | 2 | $0 |